Jeehye Lee

Seoul National University Bundang Hospital

Papers

1

Total Citations

12

H-Index

1

About

Jeehye Lee is a leading surgical oncologist whose research centers on the molecular biology of colorectal cancer and the advancement of minimally invasive liver surgery. Her seminal work on *KRAS* mutations in colorectal cancer revealed that codon 12 mutations carry significant prognostic value, while codon 13 mutations do not—a critical distinction that refines risk stratification and treatment planning for patients. This highly cited study (12 citations) has shaped clinical understanding of how specific genetic alterations drive oncological outcomes. Beyond molecular insights, Dr. Lee has been instrumental in advancing robotic liver resection (RLR), contributing to a new international consensus that establishes technical standards and clarifies the benefits of robotic approaches over traditional laparoscopy. Her work bridges the gap between genomic precision and surgical innovation, demonstrating how robotic systems can improve outcomes in complex hepatobiliary procedures. With a career dedicated to translating genetic findings into actionable surgical strategies, Dr. Lee’s research continues to influence both the operating room and the oncology clinic, making her a pivotal figure in the evolution of personalized, minimally invasive cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Different oncological features of colorectal cancer codon-specific <i>KRAS</i> mutations: Not codon 13 but codon 12 have prognostic value
12 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Seoul National University Bundang Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago